我要投票 Jinhe金河在饲料添加剂行业中的票数:8
· 外 推 电 报 ·
2024-11-24 05:22:34 星期日

【Jinhe金河是哪个国家的品牌?】

Jinhe金河是什么牌子?「Jinhe金河」是 金河生物科技股份有限公司 旗下著名品牌。该品牌发源于内蒙古,由创始人王东晓在1990期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

金河生物科技股份有限公司是一家生产和销售饲用金霉素及动物保健品为主的民营控股企业,1998年被国家科委认定为“国家重点高新技术企业”,同时也是内蒙古自治区60家重点企业之一。

公司位于青山南麓、黄河之滨的内蒙古托克托县境内,与亚洲最大的火力发电厂——大唐托克托电厂比邻相依,并与中国最大的露天煤矿——准格尔煤田隔(黄)河相望,具有得天独厚的地理优势和资源优势。

公司现拥有国际上先进的发酵生产设备和产品质量检测设备,主要工艺流程全部采用微机自动控制,现有发酵吨位5794立方米,金霉素的发酵规模居世界前列。

其主导产品“牧星”、“金河”牌饲用金霉素目前年生产能力5.3万多吨,连续六次顺利通过美国联邦政府食品与药品管理总署(FDA)的质量验收。

产品主要出口到美国、加拿大、东南亚等国家和地区,同时行销网络遍布国内各省、市(自治区),市场前景十分广阔。

作为一家高新技术企业,金河生物科技股份有限公司近年来得到了迅猛的发展,这主要得益于企业以人为本的发展思路和强大的技术支撑。

通过人才的引进和人力资源的合理配置,使企业逐步形成了自己的人才梯队,在充分发挥人才优势的群体效应的同时,在生产技术领域不断地完善与创新,为企业在知识经济时代异军突起奠定了坚实的基础。

良好的信誉、卓越的品质源于企业严格的管理和对技术创新孜孜不倦的追求。

2001-2002年,企业先后顺利通过了ISO9002质量体系认证和国家兽药企业GMP验收。

从1994年起,企业连续六次顺利通过美国联邦政府食品药品管理总署(FDA)的质量验收,并被国家九部委认定为农业产业化国家重点龙头企业。

金河生物科技股份有限公司在未来的发展进程中,将按照“面向市场、优化结构、整合资源、提高效益”的发展构想,以发酵工业为载体,以调整产品结构为主线,走外延与内涵相结合扩大再生产的科技强企之路,通过与行业精英联盟,实现资产优化和管理升级,结合基因工程等高科技手段的探索与研究,全面提升企业的整体素质和核心竞争力,进一步增强企业的经济实力和发展后劲,为民族工业的繁荣和发展做出新的更大的贡献。

英文翻译:Jinhe Biotechnology Co., Ltd. is a private holding enterprise mainly engaged in the production and sale of feed chlortetracycline and animal health products. In 1998, it was recognized as a "national key high-tech enterprise" by the State Science and Technology Commission, and also one of the 60 key enterprises in Inner Mongolia Autonomous Region. The company is located in Tuoketuo County, Inner Mongolia, on the south foot of Qingshan mountain and the Bank of the Yellow River. It is adjacent to Datang Tuoketuo Power Plant, the largest thermal power plant in Asia, and across the (yellow) River from Jungar coal field, the largest open-pit coal mine in China. It has unique geographical advantages and resource advantages. The company now has advanced fermentation production equipment and product quality testing equipment in the world. The main technological process is all controlled by computer automatically. The current fermentation tonnage is 5794 cubic meters, and the fermentation scale of chlortetracycline ranks the top in the world. Its leading products "muxing" and "Jinhe" brand feed aureomycin currently have an annual production capacity of more than 53000 tons, and have successfully passed the quality acceptance of the United States Federal Food and Drug Administration (FDA) for six consecutive times. The products are mainly exported to the United States, Canada, Southeast Asia and other countries and regions. At the same time, the marketing network is all over the domestic provinces, cities (autonomous regions), and the market prospect is very broad. As a high-tech enterprise, Jinhe Biotechnology Co., Ltd. has developed rapidly in recent years, which is mainly due to the people-oriented development ideas and strong technical support of the enterprise. Through the introduction of talents and the rational allocation of human resources, the enterprise has gradually formed its own talent echelon. While giving full play to the group effect of talent advantages, it has constantly improved and innovated in the field of production technology, laying a solid foundation for the emergence of enterprises in the era of knowledge economy. Good reputation and excellent quality come from the strict management of the enterprise and the tireless pursuit of technological innovation. From 2001 to 2002, the company has successfully passed ISO9002 quality system certification and GMP acceptance of national veterinary drug enterprises. Since 1994, the company has successfully passed the quality acceptance of the United States Federal Food and Drug Administration (FDA) for six consecutive times, and has been recognized as the national key leading enterprise of agricultural industrialization by nine ministries and commissions. In the future development process, Jinhe Biotechnology Co., Ltd. will follow the development concept of "facing the market, optimizing the structure, integrating the resources and improving the efficiency", take the fermentation industry as the carrier, adjust the product structure as the main line, take the road of expanding the renewable production through the combination of extension and connotation, and realize the asset optimization and management upgrading through the alliance with the industry elite, Combined with the exploration and research of high-tech means such as genetic engineering, we will comprehensively improve the overall quality and core competitiveness of enterprises, further enhance the economic strength and development potential of enterprises, and make new and greater contributions to the prosperity and development of national industry.

本文链接: https://www.waitui.com/brand/cc6e5eebb.html 联系电话:0471-8511111

千城特选小程序码

7×24h 快讯

上市公司回复可控核聚变概念最新动态:离商用发电还有较长距离

A股可控核聚变概念最近一周走强,东方精工、永鼎股份、弘讯科技等连续涨停。多家上市公司通过公告或互动易平台回复相关问题。①中国广核:公司关注并积极参与先进核能的研发工作,据了解,目前全球可控核聚变研发仍处于科学试验阶段,离实现商用发电还有较长距离。②海陆重工:公司拥有民用核安全设备制造许可证,可以承接核安全2、3的压力容器、热交换器。核聚变能源因其清洁、高效、可持续的特性,被视为解决未来能源危机的理想选择。国家未来的能源规划也明确提出可控核聚变是未来的主要发展方向。公司将抓住行业发展的机会,积极跟进行业动态,努力提高自身装备及技术水平,提高公司竞争力与盈利能力。③盛帮股份:公司核防护业务主要产品为个人穿戴式防护服、核工程类防护装备等。公司立足橡塑高分子材料改性研究,相关产品可应用于可控核聚变领域。④永鼎股份:公司下属控股子公司东部超导主营产品是第二代高温超导带材及超导应用产品,公司不直接生产制造可控核聚变装置,仅为绕制装置的磁体提供材料。目前,东部超导带材产量较少,2023年度营业收入占公司整体收入比重不足1%,且亏损,不会对公司业绩产生重大影响。(财联社)

2小时前

共建广域低空通信网络试验场 上海市通管局与金山区签协议

11月21日,上海市通信管理局与金山区人民政府签署“共同建设广域低空通信网络试验场,打造一体化空天网”战略合作协议。双方将厚植金山全域数字化转型,发挥各自技术和资源优势,围绕支撑低空经济发展、推动区域数字化转型、持续优化营商环境、加强网络和数据安全保障等四个方面进行紧密合作。(e公司)

2小时前

我国首条规模化民航轮胎生产线建成投产

我国首条规模化民航轮胎生产线在广西建成投产,每年可生产10万条高性能民用航空轮胎。(e公司)

2小时前

仲景食品(南阳)有限公司揭牌暨一车间试产运营

据仲景食品消息,11月23日,仲景食品(南阳)有限公司揭牌暨一车间试产仪式举行。南阳产业园一期项目占地184亩,计划建设4个车间,其中一车间主要建设了以上海葱油为代表的调味酱汁类生产线,生产线采取了先进的自动化技术和智能化设备,在生产工艺和质量方面具有显著优势,将大幅提升公司的生产能力,满足日益增长的市场需求。(e公司)

2小时前

知名私募温莎资本被注销登记

中国证券投资基金业协会11月22日公布了多份《纪律处分复核决定书》,部分私募不服纪律处分,向协会提出复核申请,协会均给予复核意见。值得注意的是,知名私募深圳温莎资本管理有限公司,因未及时报告办公地址变更信息、不配合自律检查工作等违规行为,被注销私募管理人登记。厦门京道产业投资基金管理有限公司(以下简称厦门京道)因存在虚假报送投资者信息、在管产品存在非合格投资者的违规事实,被协会公开谴责。(财联社)

2小时前

本页详细列出关于新希望六和的品牌信息,含品牌所属公司介绍,新希望六和所处行业的品牌地位及优势。
咨询